Objectives Assess the efficacy and safety profiles of different sodium-glucose cotransporter-2 inhibitors (SGLT2is) as an add-on to metformin in type 2 diabetes mellitus (T2DM) patients. Design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback